Oppenheimer & CO Inc Merck & Co., Inc. Transaction History

Oppenheimer & CO Inc

  • $5.91 Billion
  • Q1 2024

A detailed history of Oppenheimer & CO Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 198,137 shares of MRK stock, worth $26.3 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
198,137
Previous 198,275 0.07%
Holding current value
$26.3 Million
Previous $21.6 Million 20.95%
% of portfolio
0.44%
Previous 0.4%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$113.24 - $131.95 $15,627 - $18,209
-138 Reduced 0.07%
198,137 $26.1 Million
Q4 2023

Feb 13, 2024
SELL
$100.18 - $109.02 $1.52 Million - $1.66 Million
-15,213 Reduced 7.13%
198,275 $21.6 Million
Q3 2023

Nov 07, 2023
SELL
$102.95 - $114.33 $5.39 Million - $5.99 Million
-52,377 Reduced 19.7%
213,488 $22 Million
Q2 2023

Aug 02, 2023
SELL
$108.61 - $118.38 $1.33 Million - $1.45 Million
-12,247 Reduced 4.4%
265,865 $30.7 Million
Q1 2023

May 10, 2023
SELL
$102.94 - $114.86 $1.12 Million - $1.25 Million
-10,914 Reduced 3.78%
278,112 $29.6 Million
Q4 2022

Feb 07, 2023
SELL
$87.44 - $112.11 $1.85 Million - $2.38 Million
-21,203 Reduced 6.83%
289,026 $32.1 Million
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $851,977 - $957,101
-10,079 Reduced 3.15%
310,229 $26.7 Million
Q2 2022

Aug 08, 2022
BUY
$83.49 - $94.64 $944,605 - $1.07 Million
11,314 Added 3.66%
320,308 $29.2 Million
Q1 2022

May 12, 2022
BUY
$73.51 - $82.4 $1.23 Million - $1.37 Million
16,668 Added 5.7%
308,994 $25.4 Million
Q4 2021

Feb 02, 2022
BUY
$72.28 - $90.54 $1.02 Million - $1.27 Million
14,070 Added 5.06%
292,326 $22.4 Million
Q3 2021

Nov 12, 2021
SELL
$71.68 - $78.83 $424,058 - $466,358
-5,916 Reduced 2.08%
278,256 $20.9 Million
Q2 2021

Aug 03, 2021
BUY
$70.31 - $77.77 $1.35 Million - $1.5 Million
19,254 Added 7.27%
284,172 $22.1 Million
Q1 2021

May 10, 2021
SELL
$68.86 - $81.11 $193,565 - $228,000
-2,811 Reduced 1.05%
264,918 $20.4 Million
Q4 2020

Feb 11, 2021
SELL
$71.77 - $79.65 $133,205 - $147,830
-1,856 Reduced 0.69%
267,729 $21.9 Million
Q3 2020

Nov 13, 2020
SELL
$73.18 - $82.95 $388,219 - $440,049
-5,305 Reduced 1.93%
269,585 $22.4 Million
Q2 2020

Aug 11, 2020
SELL
$70.42 - $80.13 $2.96 Million - $3.37 Million
-42,076 Reduced 13.27%
274,890 $21.3 Million
Q1 2020

May 08, 2020
BUY
$63.36 - $87.82 $2.02 Million - $2.8 Million
31,846 Added 11.17%
316,966 $24.4 Million
Q4 2019

Feb 07, 2020
SELL
$77.58 - $87.54 $802,409 - $905,426
-10,343 Reduced 3.5%
285,120 $25.9 Million
Q3 2019

Oct 31, 2019
BUY
$76.08 - $82.93 $119,826 - $130,614
1,575 Added 0.54%
295,463 $24.9 Million
Q2 2019

Aug 09, 2019
SELL
$69.84 - $81.59 $487,762 - $569,824
-6,984 Reduced 2.32%
293,888 $24.6 Million
Q1 2019

Apr 24, 2019
BUY
$69.58 - $79.36 $554,970 - $632,975
7,976 Added 2.72%
300,872 $25 Million
Q4 2018

Jan 29, 2019
SELL
$65.24 - $75.71 $51,213 - $59,432
-785 Reduced 0.27%
292,896 $22.4 Million
Q3 2018

Oct 26, 2018
BUY
$57.69 - $67.84 $515,748 - $606,489
8,940 Added 3.14%
293,681 $20.8 Million
Q2 2018

Aug 10, 2018
BUY
$50.83 - $59.72 $191,120 - $224,547
3,760 Added 1.34%
284,741 $17.3 Million
Q1 2018

May 01, 2018
BUY
$50.96 - $59.23 $783,560 - $910,720
15,376 Added 5.79%
280,981 $15.3 Million
Q4 2017

Feb 07, 2018
SELL
$51.62 - $61.64 $1.55 Million - $1.85 Million
-30,008 Reduced 10.15%
265,605 $14.9 Million
Q3 2017

Nov 09, 2017
BUY
$58.67 - $63.13 $17.3 Million - $18.7 Million
295,613
295,613 $18.9 Million

Others Institutions Holding MRK

# of Institutions
3,765
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $337B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email